Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
Drug-resistant Gram-negative bacterial pathogens are an increasingly serious health threat causing worldwide nosocomial infections with high morbidity and mortality. Of these, the most prevalent and severe are Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, ...
Saved in:
Main Authors: | Panagiotis Zagaliotis (Author), Jordyn Michalik-Provasek (Author), Jason Gill (Author), Thomas Walsh (Author) |
---|---|
Format: | Book |
Published: |
Case Western Reserve University,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practical Assessment of an Interdisciplinary Bacteriophage Delivery Pipeline for Personalized Therapy of Gram-Negative Bacterial Infections
by: Silvia Würstle, et al.
Published: (2022) -
Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020) -
Aggregatibacter actinomycetemcomitans-Gram-Negative Bacterial Pathogen
Published: (2021) -
Gram Negative Bacterial Toe Web Intertrigo
by: Laura Atzori, et al.
Published: (2014) -
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
by: Nicola Principi, et al.
Published: (2019)